Curriculum Vitae - Curriculum vitae of
a.o. Univ. Prof. Dr. med. Tamara Kopp
Focal points
- Skin cancer screening/moles check: white and black skin cancer
- Dermatological surgery: removal of moles, warts, white and black skin cancer
- Aesthetic dermatology: Injectable treatments with botulinum toxin (Botox), hyaluronic acid, etc.
- Laser medicine: skin rejuvenation, pigment spots, melasma, veins, couperose
- Radiofrequency microneedling
- Allergy diagnostics and treatment: allergen chip, prick test, epicutaneous test, laboratory diagnostics, specific immunotherapy
- Pigment disorders: Melasma, lentigines solares
- Acne: acne vulgaris, acne rosacea, couperose
- Peelings (TCA & fruit acid)
- Psoriasis
Education & professional activities
Professional activity | Period |
---|---|
Owner of JUVENIS | June 1, 2021 |
Founding partner of JUVENIS | october 2012 |
Surgery at the Vienna Private Clinic | 2004 to 2012 |
Senior physician at the University Clinic for Dermatology, Vienna General Hospital | 2004 to 2012 |
Ward manager and head of the allergy outpatient clinic | |
International Management Project Medical University of Vienna International (MUVI) and Voest Alpine Medicine (VAMED) Prince Court Medical Center SDN BHD (PCMC)Kuala Lumpur, Malaysia |
July 4, 2007 |
Venia docendi and appointment as associate university professor | 2004 |
Specialist training in dermatology and venereology, Vienna General Hospital | 1997 to 2004 |
Dissertation and post-doctoral fellowship at the Harvard Skin Disease Research Center, Harvard University, Boston, MA, USA and Research work at the University Clinic for Dermatology, Vienna General Hospital |
1993 to 1997 |
Doctorate in medicine at the University of Vienna | 1994 |
Awards and prizes
Awards | Period |
---|---|
Heinrich Auspitz Prize of the ÖGDV award winners | 2015 |
Award 2004 - "Theodor Billroth Prize" | 2004 |
UNILEVER Prize winners | 2003 |
Publications
Publications | Period |
---|---|
Clinical improvement in psoriasis with specific targeting of interleukin-23.ÖGDV Award Winner Kopp T, Riedl E, Bangert C, Bowman EP, Greisenegger E, Horowitz A, Kittler H, Blumenschein WM, McClanahan TK, Marbury T, Zachariae C, Xu D, Hou XS, Mehta A, Zandvliet AS, Montgomery D, van Aarle F, Khalilieh S. Nature. 2015 May 14;521(7551):222-6. |
May 14, 2015 |
Specific roles for dendritic cell subsets during initiation and progression of psoriasis Glitzner E, Korosec A, Brunner PM, Drobits B, Amberg N, Schonthaler HB, Kopp T, Wagner EF, Stingl G, Holcmann M, Sibilia M. EMBO Mol Med. 2014 Sep 12;6 (10):1312-27 |
Sept. 12, 2014 |
Association of the chromosome 11q13.5 variant with atopic dermatitis in Austrian patients Greisenegger EK, Zimprich F, Zimprich A, Gleiss A, Kopp T. Eur J Dermatol. 2013 Apr 1;23(2):142-5. |
April 2013 |
Analysis of four prevalent filaggrin mutations (R501X, 2282del4, R2447X and S3247X) in Austrian and German patients with atopic dermatitis Greisenegger EK, Novak N, Maintz L, Bieber T, Zimprich F, Haubenberger D, Gleiss A, Stingl G, Kopp T*, Zimprich A*. *Equally contributing authors (J Eur Acad Dermatol Venereol. 2010; 24:607-610)/ |
2010 |
Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells. G. Stary, C. Bangert, M. Tauber, R. Strohal, *T. Kopp, *G. Stingl. Equal last authorship (J. Exp. Med 2007; 204:1441-51) |
2007 |
Immunopathologic features of allergic contact dermatitis in man: participation of plasmacytoid dendritic cells in the pathogenesis of the disease? C. Bangert, J. Friedl, G. Stary, G. Stingl, T. Kopp (J. Invest. Dermatol., 2003; 121:1409-1418) |
2003 |
IL-23 production by cosecretion of transgenic p40 with endogenous p19 in K14/p40 transgenic mice. Evidence for enhanced cutaneous immunity. T. Kopp, P. Lenz, C. Bello-Fernandez, R. Kastelein, T.S. Kupper and G. Stingl (J. Immunol., 2003; 170:5438-5444) |
2003 |
Inflammatory skin disease in K14/p40 transgenic mice. Evidence for IL-12-like activities of p40 T. Kopp, J.D. Kieffer, A. Rot, S. Strommer, G. Stingl and T.S. Kupper (J. Invest. Dermatol., 2001; 117: 618-626) |
2001 |
Keratinocyte expression of the type 2 IL-1 receptor (IL-1R2) mediates local and specific inhibition of IL-1 mediated inflammation T. Rauschmayr, R. W. Groves and T.S. Kupper (Proc.Natl.Acad.Sci.U.S.A. 1997; 94:5814-5819) |
1997 |
Distinct roles for B7 costimulation in contact hypersensitivity and humoral immune responses to epicutaneous antigen T. Rauschmayr-Kopp, I.R. Williams, F. Borriello, A.H. Sharpe and T.S. Kupper (Eur. J. Immunol., 1998; 28:4221-4227) |
1998 |
Memberships
Languages
- German and English
...what does attractiveness mean to you?
For me, attractiveness means a successful cocktail of personality, charisma, charisma, appearance and outer beauty.